KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
AcquisitionsAmortization of Deferred ChargesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Dividends Paid - CommonFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesSales of Property, Plant and EquipmentShare-based CompensationShares IssuedShort-Term Debt issuances
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Chemed (CHE) Change in Accured Expenses (2016 - 2025)

Chemed (CHE) has 17 years of Change in Accured Expenses data on record, last reported at $4.1 million in Q4 2025.

  • For Q4 2025, Change in Accured Expenses fell 7.54% year-over-year to $4.1 million; the TTM value through Dec 2025 reached $10.4 million, down 54.18%, while the annual FY2025 figure was $10.4 million, 54.18% down from the prior year.
  • Change in Accured Expenses reached $4.1 million in Q4 2025 per CHE's latest filing, down from $4.8 million in the prior quarter.
  • Across five years, Change in Accured Expenses topped out at $13.3 million in Q1 2024 and bottomed at -$5.1 million in Q3 2022.
  • Average Change in Accured Expenses over 5 years is $2.7 million, with a median of $3.1 million recorded in 2022.
  • The widest YoY moves for Change in Accured Expenses: up 328.93% in 2022, down 249.56% in 2022.
  • A 5-year view of Change in Accured Expenses shows it stood at -$1.4 million in 2021, then skyrocketed by 328.93% to $3.2 million in 2022, then tumbled by 57.07% to $1.4 million in 2023, then surged by 219.84% to $4.4 million in 2024, then decreased by 7.54% to $4.1 million in 2025.
  • Per Business Quant database, its latest 3 readings for Change in Accured Expenses were $4.1 million in Q4 2025, $4.8 million in Q3 2025, and $570000.0 in Q2 2025.